DIVINHEALSimplifying Global Wellbeing
Home
Treatments
Hospitals
Doctors
Page background

Targeted Molecular Therapy Treatment in Hyderabad for UAE

About

Targeted Molecular Therapy in Hyderabad for UAE Patients

UAE patients seeking advanced cancer care often face complex decisions. The thought of Targeted Molecular Therapy can bring hope, but also questions about access, expertise, and managing treatment away from home with confidence.

Hyderabad stands out as a preferred destination for its world-class medical infrastructure and specialized oncology centers. Patients choose Hyderabad for its renowned doctors, comprehensive care environment, and commitment to innovative treatments.

The city’s leading hospitals offer cutting-edge Targeted Molecular Therapy, supported by multidisciplinary teams. This ensures seamless treatment pathways and accessible follow-up care within a supportive medical community dedicated to international patients.

Is Hyderabad the right choice for your Targeted Molecular Therapy journey?

What is Targeted Molecular Therapy?

Targeted Molecular Therapy represents a significant advancement in cancer treatment. Unlike traditional chemotherapy, which affects rapidly dividing cells indiscriminately, molecular therapies specifically target molecules crucial for cancer cell growth, survival, and spread. These treatments work by identifying and attacking specific genetic mutations or proteins unique to cancer cells, thereby minimizing damage to healthy cells. This personalized approach often leads to fewer side effects and improved outcomes for eligible patients, offering a more precise way to fight various types of cancer.

What are the different types of Targeted Molecular Therapy?

Targeted Molecular Therapy encompasses a range of approaches, each designed to interfere with specific molecular pathways:

  • Kinase Inhibitors: These drugs block the activity of enzymes called kinases, which are involved in cell growth and division. Many cancers rely on overactive kinases.
  • Monoclonal Antibodies: These engineered antibodies target specific proteins on the surface of cancer cells or proteins that help cancer grow, marking them for destruction by the immune system or blocking their function.
  • Angiogenesis Inhibitors: These therapies prevent the formation of new blood vessels that tumors need to grow and spread, effectively starving the cancer cells.
  • PARP Inhibitors: These drugs block an enzyme called PARP, making it harder for cancer cells with certain genetic mutations (like BRCA) to repair their DNA, leading to cell death.
  • Proteasome Inhibitors: These medications disrupt the proteasome, a cellular complex that breaks down proteins. By inhibiting this, abnormal proteins accumulate, leading to cancer cell death.

When is Targeted Molecular Therapy recommended?

  • When specific genetic mutations or molecular targets are identified in a patient's cancer cells.
  • For certain types of cancers, such as lung cancer, breast cancer, colorectal cancer, melanoma, and specific leukemias, where molecular targets are well-established.
  • If traditional treatments like chemotherapy or radiation have been ineffective or poorly tolerated.
  • As part of a personalized treatment plan aimed at reducing side effects compared to conventional therapies.
  • In advanced or metastatic cancers to control disease progression and improve quality of life.
  • When laboratory tests confirm the presence of specific biomarkers indicating the likely responsiveness to a targeted drug.

What evaluations are needed before treatment?

  • Comprehensive medical history review and physical examination.
  • Advanced genetic and molecular testing of tumor tissue to identify specific biomarkers and mutations (e.g., NGS, FISH, IHC).
  • Blood tests, including complete blood count, liver and kidney function tests, and tumor markers.
  • Imaging scans such as CT, MRI, or PET scans to assess the extent of the cancer and potential spread.
  • Biopsy review by a specialized pathologist to confirm cancer type and characteristics.
  • Cardiac evaluation, including an ECG or echocardiogram, for certain therapies that may affect heart function.
  • Consultation with a multidisciplinary team, including oncologists, geneticists, and radiologists, to finalize the treatment plan.

How is Targeted Molecular Therapy administered?

The administration of Targeted Molecular Therapy varies depending on the specific drug, cancer type, and patient condition, designed to best suit individual needs.

Oral Medication

Many targeted therapies are available in pill form, allowing patients to take them at home. This often involves a daily regimen, and careful adherence to dosage and schedule is crucial for effectiveness. Regular monitoring and follow-up appointments are necessary to assess response and manage any potential side effects.

Intravenous Infusion

Some targeted therapies are administered intravenously, meaning they are given directly into a vein through an infusion. These treatments are typically conducted in an outpatient clinic or hospital setting over a specific duration, which can range from minutes to several hours. Infusions are usually scheduled in cycles, with breaks in between.

What does recovery after treatment involve?

Recovery from Targeted Molecular Therapy is often a more gradual and ongoing process compared to traditional treatments, focusing on sustained management rather than a single acute recovery phase. Patients typically monitor for and manage side effects, which are generally milder but can include fatigue, skin rashes, diarrhea, or liver function changes. Regular follow-up appointments with the oncology team are essential to assess the treatment's effectiveness, adjust dosages if needed, and address any lingering symptoms. Lifestyle adjustments, including diet and activity levels, are often recommended to support overall well-being. Long-term recovery emphasizes maintaining a good quality of life and continuing surveillance for cancer recurrence or progression, under close medical guidance.

What are the risks and success rates of Targeted Molecular Therapy?

  • Common side effects include skin rash, diarrhea, fatigue, and mouth sores.
  • Some targeted therapies can affect heart function or cause high blood pressure.
  • Potential for liver or kidney function abnormalities requiring close monitoring.
  • Risk of developing resistance to the therapy over time, leading to disease progression.
  • Neurological side effects or blood clotting issues are rare but possible.
  • Hypersensitivity reactions or allergic responses, especially with intravenous infusions.

The success rates of Targeted Molecular Therapy vary significantly based on the type of cancer, its stage, the specific molecular target, and individual patient factors. While not a cure for all cancers, these therapies often lead to significant disease control, tumor shrinkage, and extended progression-free survival for many patients. In some cases, they can induce long-lasting remissions. The goal is often to improve prognosis, reduce symptoms, and enhance the patient's quality of life. Results depend heavily on careful patient selection through precise molecular profiling, ensuring the therapy matches the cancer's unique characteristics.

Considering Targeted Molecular Therapy in Hyderabad?

Our expert team can provide a personalized treatment plan and cost estimate tailored to your needs. Reach out today for guidance.

What is the cost of Targeted Molecular Therapy in Hyderabad?

Cost of Targeted Molecular Therapy in Hyderabad

The cost of Targeted Molecular Therapy in Hyderabad is generally more affordable than in many Western countries, without compromising on quality of care. Several factors influence the overall expense, including the specific type of targeted drug required, the duration of treatment, the hospital chosen, and any associated procedures like advanced diagnostics. Hyderabad offers competitive pricing for these cutting-edge treatments.

Location Estimated Cost (USD)
Hyderabad, India $12,000 - $35,000
United States $80,000 - $150,000+
United Kingdom $60,000 - $110,000
Singapore $45,000 - $85,000
Germany $50,000 - $95,000

How Hyderabad Hospitals Support International Patients

  • Dedicated international patient coordinators for seamless communication and support.
  • Assistance with visa applications and necessary travel documentation.
  • Arrangement of airport transfers and comfortable local accommodation.
  • Language interpretation services to ensure clear understanding between patients and medical staff.
  • Guidance on local transportation, dining, and other personal needs.
  • Facilitation of teleconsultations with specialists before and after your visit.
  • Support for family members accompanying the patient during their stay.

Essential Documents for Your Treatment Journey

  • Valid passport and medical visa for entry into India.
  • Comprehensive medical reports, including diagnosis, previous treatments, and recent test results.
  • Doctor's referral letter outlining the recommended Targeted Molecular Therapy.
  • Proof of financial capability or health insurance details for covering treatment costs.
  • A list of all current medications, including dosages.
  • Copies of any relevant genetic or molecular profiling reports.
  • Contact information for your primary care physician or referring doctor back home.

Preparing for Your Targeted Therapy in Hyderabad

  • Undergo a thorough medical review to confirm suitability for Targeted Molecular Therapy.
  • Arrange your travel itinerary, ensuring adequate time for consultations and treatment cycles.
  • Secure comfortable accommodation in Hyderabad that suits your needs and proximity to the hospital.
  • Plan your finances, confirming coverage or having funds ready for medical expenses and living costs.
  • Understand the specific pre-treatment instructions from your Hyderabad medical team.
  • Pack essential personal items and any comfort items that might aid your stay.
  • Familiarize yourself with local customs and transportation options in Hyderabad.

Aftercare and Follow Up Support

  • Strictly adhere to the prescribed medication schedule and dosage following treatment.
  • Follow dietary and lifestyle recommendations provided by your medical team.
  • Monitor for any new or worsening side effects and report them promptly to your doctor.
  • Attend all scheduled follow-up appointments and diagnostic tests in Hyderabad or remotely.
  • Maintain open communication with your treating oncologist for ongoing guidance and support.
  • Arrange for any necessary rehabilitation or physical therapy if advised.
  • Plan for continued monitoring and long-term care, either in Hyderabad or with your local doctor.

Ready to explore your treatment options?

Connect with Hyderabad's leading oncology specialists to understand how Targeted Molecular Therapy can benefit you. Your journey to better health begins with an informed decision.

Begin Your Path to Recovery

Your health journey deserves expert care and clear guidance. We are here to help you navigate your options for Targeted Molecular Therapy in Hyderabad with confidence and support.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Noaline Sinha

Dr. Noaline Sinha

Chairperson - Nuclear Medicine & Radio-Theranostics

Nuclear Medicine

New Delhi

15+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Shubhra Shri Gupta

Dr. Shubhra Shri Gupta

Sr. Consultant

Medical Oncology & Hemato Oncology

New Delhi

9+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Prasun Chatterjee

Dr. Prasun Chatterjee

Director - Medical Oncology

Medical Oncology

New Delhi

17+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Anshuman Manaswi

Dr. Anshuman Manaswi

Senior Consultant Plastic Surgeon

Plastic Surgery

New Delhi

19+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Pramod Kumar Julka

Dr. Pramod Kumar Julka

Senior Oncologist, Max Healthcare; Former Dean & Professor, AIIMS

Cancer Care & Oncology

New Delhi

15+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Pankaj Dougall

Dr. Pankaj Dougall

Principal Director & Head – Nuclear Medicine

Nuclear Medicine

New Delhi

38+ Years

Experience

Max Hospital,Gurgaon

Hospital

1500

Fees

View Details
Dr. Sushil Gupta

Dr. Sushil Gupta

Director, Medical Oncology

Medical Oncology

New Delhi

30+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. H S Bhatyal

Dr. H S Bhatyal

Director

Medical Oncology

New Delhi

44+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. C.P.S. Chauhan

Dr. C.P.S. Chauhan

Principal Director & Chief of Medical Oncology

Medical Oncology

New Delhi

30+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Naresh Aggarwal

Dr. Naresh Aggarwal

Sr. Consultant

Medical Oncology

New Delhi

29+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Nikhil Agrawal

Dr. Nikhil Agrawal

Director - Medical Oncology

Medical Oncology

New Delhi

20+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Alok Gupta

Dr. Alok Gupta

Director

Oncology

New Delhi

26+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Vijay Kumar

Dr. Vijay Kumar

Director & Head

Medical Oncology & Haematology

New Delhi

20+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dodul Mondal

Dodul Mondal

Sr. Consultant

Medical & Haemato Oncology

New Delhi

8+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Manik Sharma

Dr. Manik Sharma

Director

Medical Oncology

New Delhi

13+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details
Dr. Ivan Singh

Dr. Ivan Singh

Director - Medical Oncology

Medical Oncology

New Delhi

13+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

क्या आप अपनी चिकित्सा यात्रा शुरू करने के लिए तैयार हैं?

भारत के शीर्ष अस्पतालों से व्यक्तिगत चिकित्सा उपचार विकल्प प्राप्त करें। हमारे चिकित्सा विशेषज्ञ हर कदम पर आपकी सहायता करने के लिए तैयार हैं।